HIV-1 gag-virus-like particles induce natural killer cell immune responses via activation and maturation of dendritic cells

Journal of Innate Immunity

Volumn 4, Issue 2, 2012, Pages 187-200

  Chang, Myint Oo ^a   Suzuki, Tomoyuki ^b   Suzuki, Hitoshi ^b   Takaku, Hiroshi ^a,b  

^a High Technology Research Centre   (Japan)

^b CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Dendritic cells; Gag virus like particles; HIV; Innate immunity; Natural killer cells

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GAG PROTEIN; VIRUS LIKE PARTICLE VACCINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS LIKE AGENT;

ANIMALS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C;

EID: 84857793927     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000329226     Document Type: Article

References (49)

1. Murphey-Corb M: Live-attenuated HIV vaccines: How safe is safe enough? Nat Med 1997; 3: 17-18. (Pubitemid 27019128)
2. Ruprecht RM: Live attenuated AIDS viruses as vaccines: Promise or peril? Immunol Rev 1999; 170: 135-149. (Pubitemid 29490751)
3. Robertson JS, Griffiths E: Assuring the quality, safety, and efficacy of DNA vaccines. Mol Biotechnol 2001; 17: 143-149. (Pubitemid 32463713)
4. Noad R, Roy P: Virus-like particles as immunogens. Trends Microbiol 2003; 11: 438-444. (Pubitemid 37101484)
5. Grgacic EV, Anderson DA: Virus-like particles: Passport to immune recognition. Methods 2006; 40: 60-65. (Pubitemid 44415499)
6. Ludwig C, Wagner R: Virus-like particles -universal molecular toolboxes. Curr Opin Biotechnol 2007; 18: 537-545.
7. Doan LX, Li M, Chen C, Yao Q: Virus-like particles as HIV-1 vaccines. Rev Med Virol 2005; 15: 75-88. (Pubitemid 40343192)
8. Young KR, McBurney SP, Karkhanis LU, Ross TM: Virus-like particles: Designing an effective AIDS vaccine. Methods 2006; 40: 98-117. (Pubitemid 44415502)
9. Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, Kamin-Lewis R, Abdelwahab S, Lewis GK, Buonaguro FM: Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J Virol 2006; 80: 9134-9143. (Pubitemid 44362963)
10. Tsunetsugu-Yokota Y, Morikawa Y, Isogai M, Kawana-Tachikawa A, Odawara T, Nakamura T, Grassi F, Autran B, Iwamoto A: Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs. J Virol 2003; 77: 10250-10259. (Pubitemid 37129668)
11. Morón VG, Rueda P, Sedlik C, Leclerc C: In vivo, dendritic cells can cross-present viruslike particles using an endosome-to-cytosol pathway. J Immunol 2003; 171: 2242-2250. (Pubitemid 37025529)
12. Deml L, Wild J, Wagner R: Virus-like particles: A novel tool for the induction and monitoring of both T-helper and cytotoxic Tlymphocyte activity. Methods Mol Med 2004; 94: 133-157.
13. Paliard X, Liu Y, Wagner R, Wolf H, Baenziger J, Walker CM: Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8 + cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS Res Hum Retroviruses 2000; 16: 273-282. (Pubitemid 30111963)
14. Deml L, Speth C, Dierich MP, Wolf H, Wagner R: Recombinant HIV-1 Pr55gag viruslike particles: Potent stimulators of innate and acquired immune responses. Mol Immunol 2005; 42: 259-277. (Pubitemid 39361454)
15. Buonaguro L, Visciano ML, Tornesello ML, Tagliamonte M, Biryahwaho B, Buonaguro FM: Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A viruslike particles administered by different routes of inoculation. J Virol 2005; 79: 7059-7067. (Pubitemid 40677337)
16. Sailaja G, Skountzou I, Quan FS, Compans RW, Kang SM: Human immunodeficiency virus-like particles activate multiple types of immune cells. Virology 2007; 362: 331-341. (Pubitemid 46678140)
17. Speth C, Bredl S, Hagleitner M, Wild J, Dierich M, Wolf H, Schroeder J, Wagner R, Deml L: Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes. Virology 2008; 382: 46-58.
18. Inaba K, Metlay JP, Crowley MT, Witmer-Pack M, Steinman RM: Dendritic cells as antigen presenting cells in vivo. Int Rev Immunol 1990; 6: 197-206.
19. Steinman RM, Hemmi H: Dendritic cells: Translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17-58. (Pubitemid 47413194)
20. Steinman RM, Banchereau J: Taking dendritic cells into medicine. Nature 2007; 449: 419-426. (Pubitemid 47509552)
21. Zitvogel L: Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002; 195:F9-F14. (Pubitemid 34461485)
22. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA: NK cell and DC interactions. Trends Immunol 2004; 25: 47-52. (Pubitemid 38032807)
23. Moretta A: The dialogue between human natural killer cells and dendritic cells. Curr Opin Immunol 2005; 17: 306-311. (Pubitemid 40692667)
24. Brilot F, Strowig T, Munz C: NK cells interactions with dendritic cells shape innate and adaptive immunity. Front Biosci 2008; 13: 6443-6454.
25. Wehner R, Dietze K, Bachmann M, Schmitz M: The bidirectional crosstalk between human dendritic cells and natural killer cells. J Innate Immun 2011; 3: 258-263.
26. Andoniou CE, Coudert JD, Degli-Esposti MA: Killers and beyond: NK-cell-mediated control of immune responses. Eur J Immunol 2008; 38: 2938-2942.
27. Brandstadter JD, Yang Y: Natural killer cell responses to viral infection. J Innate Immun 2011; 3: 274-279.
28. Guilmot A, Hermann E, Braud VM, Carlier Y, Truyens C: Natural killer cell responses to infections in early life. J Innate Immun 2011; 3: 280-288.
29. Kottilil S, Chun TW, Moir S, Liu S, McLaughlin M, Hallahan CW, Maldarelli F, Corey L, Fauci AS: Innate immunity in human immunodeficiency virus infection: Effect of viremia on natural killer cell function. J Infect Dis 2003; 187: 1038-1045. (Pubitemid 36399345)
30. Fauci AS, Mavilio D, Kottilil S: NK cells in HIV infection: Paradigm for protection or targets for ambush. Nat Rev Immunol 2005; 5: 835-843. (Pubitemid 41581665)
31. Osada T, Clay T, Hobeika A, Lyerly HK, Morse MA: NK cell activation by dendritic cell vaccine: A mechanism of action for clinical activity. Cancer Immunol Immunother 2006; 55: 1122-1131. (Pubitemid 43800727)
32. Fantuzzi L, Purificato C, Donato K, Belardelli F, Gessani S: Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: A novel mechanism for AIDS pathogenesis. J Virol 2004; 78: 9763-9772. (Pubitemid 39187094)
33. Becker Y: HIV-1 induced AIDS is an allergy and the allergen is the Shed gp120 -a review, hypothesis, and implications. Virus Genes 2004; 28: 319-331. (Pubitemid 39012133)
34. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT: HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004; 5: 233-236. (Pubitemid 38332116)
35. Buonaguro L, Tornesello ML, Gallo RC, Marincola FM, Lewis GK, Buonaguro FM: Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles. J Virol 2009; 83: 304-313.
36. Cohen J: HIV/AIDS. Vaccine results lose significance under scrutiny. Science 2003; 299: 1495. (Pubitemid 36297677)
37. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD: Strong cytotoxic T cell and weak neutralizing antibody response in a subset of persons with stable nonprogression HIV type I infection. AIDS Res Hum Retroviruses 1996; 12: 585-592. (Pubitemid 26120291)
38. Schellens IM, Borghans JA, Jansen CA, De Cuyper IM, Geskus RB, van Baarle D, Miedema F: Abundance of early functional HIVspecific CD8 + T cells does not predict AIDSfree survival time. PLoS One 2008; 3:e2745.
39. Vaccination and enrollment are discontinued in phase II trials of Merck's investigational HIV vaccine candidate. Press release from Merck and the HIV Vaccine Trials Network, Sept 21, 2007. http://www.hvtn.org/pdf/FINAL-HIV- Vaccine-Press-Release. pdf.
40. Cooper MA, Colonna M, Yokoyama WM: Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep 2009; 10: 1103-1110.
41. Cooper MA, Yokoyama WM: Memory-like responses of natural killer cells. Immunol Rev 2010; 235: 297-305.
42. Sun JC, Beilke JN, Lanier LL: Adaptive immune features of natural killer cells. Nature 2009; 457: 557-561.
43. Ugolini S, Vivier E: Immunology: Natural killer cells remember. Nature 2009; 457: 544-545.
44. Paust S, Senman B, von Andrian UH: Adaptive immune responses mediated by natural killer cells. Immunol Rev 2010; 235: 286-296.
45. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216. (Pubitemid 34293424)
46. Yoshida O, Akbar F, Miyake T, Abe M, Matsuura B, Hiasa Y, Onji M: Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: Restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell. Clin Exp Immunol 2008; 152: 174-181. (Pubitemid 351347553)
47. Austyn JM, Kupiec-Weglinski JW, Hankins DF, Morris PJ: Migration patterns of dendritic cells in the mouse. Homing to T celldependent areas of spleen, and binding within marginal zone. J Exp Med 1988; 167: 646-651. (Pubitemid 18073661)
48. Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ: Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res 1999; 59: 3340-3345. (Pubitemid 29334488)
49. Barratt-Boyes SM, Zimmer MI, Harshyne LA, Meyer EM, Watkins SC, Capuano S 3rd, Murphey-Corb M, Falo LD Jr, Donnenberg AD: Maturation and trafficking of monocyte-derived dendritic cells in monkeys: Implications for dendritic cell-based vaccines. J Immunol 2000; 164: 2487-2495. (Pubitemid 30115478)